Review Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Indicator: In combination with chemotherapy, for that treatment method of Grownup clients with domestically recurrent unresectable or metastatic triple-detrimental breast most cancers that have not received prior chemotherapy for metastatic ailment and whose tumours express programmed